An interventional study of Surgical treatment of pilonidal sinus disease in Pilonidal Sinus, sponsored by Atlas University. Completed. Per ClinicalTrials.gov, last updated 2023-05-10.
Sponsored by Atlas University · Not applicable, Interventional, and Treatment
Sacrococcygeal pilonidal sinus disease (PSD) has been defined as a disease characterized by chronic inflammation and recurrent infections caused by the movement of hair toward the gluteal sulcus. This condition is especially seen in young men and negatively affects the quality of life of patients and prevents them from performing their work and school activities. The treatment options for PSD range from the use of antibiotics alone to reconstructed excision with tissue flaps. Although the optimal surgical treatment option remains controversial, expectations from the ideal surgical treatment include low recurrence and postoperative complication rates, early wound healing, short hospital stay, early return to work, and good cosmetic outcomes. The aim of this study was to compare the efficacy of the different flap techniques in the surgical treatment of PSD and evaluate the long-term outcomes of patients.
109 studies on the registry are indexed under Pilonidal Sinus; 32 are open to participants now.
This study's enrollment of 102 is above the median of 80 across 72 interventional studies indexed under Pilonidal Sinus.
Browse Pilonidal Sinus studies →Atlas University is the lead sponsor of 96 studies on the registry; 25 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A weakened immune system. It can come from an illness, such as HIV or some blood cancers, or from medicines that turn the immune system down, for example after an organ transplant or for an autoimmune disease; steroids at higher doses count.
Read whether the line is about a condition or about medicines, and which medicines and doses it means.
Immunosuppression
A weakened immune system. It can come from an illness, such as HIV or some blood cancers, or from medicines that turn the immune system down, for example after an organ transplant or for an autoimmune disease; steroids at higher doses count.
Read whether the line is about a condition or about medicines, and which medicines and doses it means.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Patients operated with the bilateral parallel elliptic flap technique.
Procedure: Surgical treatment of pilonidal sinus disease
Patients operated with the karydakis flap technique.
Procedure: Surgical treatment of pilonidal sinus disease
Advancement flap techniques in surgical treatment of pilonidal sinus disease.
Time taken to return to work/school
Time to return to work in daily life after surgery
Time frame: The patients' return to work ranged from 11 to 49 days.
Postoperative pain
The pain scores of the patients were determined on the first postoperative day. The Visual Analog Scale (VAS), scored from 1 to 10, was administered to the patients to evaluate their postoperative pain levels.
Time frame: 1 day
Length of hospital stay
Time to discharge from hospital after surgery
Time frame: The patients' length of hospital stay ranged from 1 to 4 days.
Recurrence of the disease
Recurrence of the disease
Time frame: 43 months
No study locations are listed for this record.
Plan to share: Yes — All IPD that underlie results in a publication
Supporting information: Study protocol, Clinical study report
Time frame: One year from the date of publication.
Ran from Jun 2016 to primary completion in Jan 2017, 7 months.
Of 35 interventional studies with no phase under Pilonidal Sinus, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 35. This study's 7 months is below that.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Apr 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Atlas University